LBA2 Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study
| Autor: | Colombo, N., Dubot, C., Lorusso, D., Cáceres, V., Hasegawa, K., Shapira-Frommer, R., Tewari, K.S., Salman, P., Hoyos, E., Yañez, E., Gumus, M., Olivera Hurtado de Mendoza, M., Samouëlian, V., Castonguay, V., Arkhipov, A., Toker, S., Li, K., Keefe, S.M., Monk, B.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1307-S1308 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|